Unlock stock picks and a broker-level newsfeed that powers Wall Street.
2.2300
-0.0100
(-0.45%)
At close: April 1 at 4:00:00 PM EDT
2.2300
0.00
(0.00%)
Pre-Market: 8:12:31 AM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 1 | -- | 1 | 1 |
| Avg. Estimate | 54k | -- | 201k | 232k |
| Low Estimate | 54k | -- | 201k | 232k |
| High Estimate | 54k | -- | 201k | 232k |
| Year Ago Sales | 290k | -- | 370k | 201k |
| Sales Growth (year/est) | -81.38% | -- | -45.68% | 15.42% |
Earnings History
| Currency in USD | 3/31/2024 | 6/30/2024 | 9/30/2024 | 12/31/2024 |
|---|---|---|---|---|
| EPS Est. | -5.04 | -3.96 | -2.64 | -2.4 |
| EPS Actual | -8.04 | -2.76 | -1.68 | -2.28 |
| Difference | -3 | 1.2 | 0.96 | 0.12 |
| Surprise % | -59.52% | 30.30% | 36.36% | 5.00% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| ONVO | -- | -- | -- | -- |
| S&P 500 | 6.69% | 6.80% | 9.98% | 14.34% |
Upgrades & Downgrades
| Downgrade | HC Wainwright & Co.: Buy to Neutral | 8/8/2019 |
| Initiated | HC Wainwright & Co.: Buy | 12/13/2018 |
| Downgrade | Raymond James: Outperform to Market Perform | 11/10/2017 |
| Initiated | Raymond James: Outperform | 1/25/2017 |
| Initiated | BTIG: Buy | 12/15/2016 |
| Initiated | Evercore ISI Group: Buy | 11/28/2016 |
Related Tickers
ENVB Enveric Biosciences, Inc.
1.3100
-5.76%
IBO Impact BioMedical Inc.
0.8200
-5.75%
RNAZ TransCode Therapeutics, Inc.
0.5409
+9.27%
VRPX Virpax Pharmaceuticals, Inc.
1.2800
+6.67%
CDT Conduit Pharmaceuticals Inc.
0.7221
-7.54%
WINT Windtree Therapeutics, Inc.
1.2000
-4.76%
PSTV Plus Therapeutics, Inc.
1.0200
+7.36%
SNSE Sensei Biotherapeutics, Inc.
0.3450
-12.44%
GRI GRI Bio, Inc.
2.0200
-36.88%
CERO CERo Therapeutics Holdings, Inc.
0.7200
-1.37%